Поиск
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.

Список литературы

  1. Glynne-Jones, R., et al., Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Eur J Surg Oncol, 2014. 40(10): p. 1165-76.
  2. Hoots, B.E., et al., Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer, 2009. 124(10): p. 2375-83.
  3. Laghi, A., et al., Magnetic Resonance Imaging of the anal canal using high resolution sequences and phased array coil: visualization of anal sphincter complex. La Radiologia medica, 2002. 103(4): p. 353-359.
  4. Stoker, J., et al., Imaging of anorectal disease. British journal of surgery, 2000. 87(1): p. 10-27.
  5. Goh, V., et al., Magnetic resonance imaging assessment of squamous cell carcinoma of the anal canal before and after chemoradiation: can MRI predict for eventual clinical outcome? International Journal of Radiation Oncology* Biology* Physics, 2010. 78(3): p. 715-721.
  6. Kachnic, L.A., et al., RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal. Int J Radiat Oncol Biol Phys, 2013. 86(1): p. 27-33.
  7. Bazan, J.G., et al., Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal. Cancer, 2011. 117(15): p. 3342-51.
  8. Dewas, C.V., et al., Does gap-free intensity modulated chemoradiation therapy provide a greater clinical benefit than 3D conformal chemoradiation in patients with anal cancer? Radiat Oncol, 2012. 7: p. 201.
  9. Ortholan, C., et al., Anal canal cancer: management of inguinal nodes and benefit of prophylactic inguinal irradiation (CORS-03 Study). Int J Radiat Oncol Biol Phys, 2012. 82(5): p. 1988-95.
  10. Matthews, J.H., et al., T1-2 anal carcinoma requires elective inguinal radiation treatment--the results of Trans Tasman Radiation Oncology Group study TROG 99.02. Radiother Oncol, 2011. 98(1): p. 93-8.
  11. Zilli, T., et al., Elective inguinal node irradiation in early-stage T2N0 anal cancer: prognostic impact on locoregional control. Int J Radiat Oncol Biol Phys, 2013. 87(1): p. 60-6.
  12. Janssen, S., et al., Anal cancer treated with radio-chemotherapy: correlation between length of treatment interruption and outcome. Int J Colorectal Dis, 2009. 24(12): p. 1421-8.
  13. Meyer, A., et al., Chemoradiotherapy in patients with anal cancer: impact of length of unplanned treatment interruption on outcome. Acta Oncol, 2006. 45(6): p. 728-35.
  14. Konski, A., et al., Evaluation of planned treatment breaks during radiation therapy for anal cancer: update of RTOG 92-08. Int J Radiat Oncol Biol Phys, 2008. 72(1): p. 114-8.
  15. Gunderson, L.L., et al., Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin. J Clin Oncol, 2012. 30(35): p. 4344-51.
  16. James, R.D., et al., Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 x 2 factorial trial. Lancet Oncol, 2013. 14(6): p. 516-24.
  17. Faivre, C., et al., [5-fluorouracile and cisplatinum combination chemotherapy for metastatic squamous-cell anal cancer]. Bulletin du cancer, 1999. 86(10): p. 861-865.
  18. Mullen, J.T., et al., Results of surgical salvage after failed chemoradiation therapy for epidermoid carcinoma of the anal canal. Ann Surg Oncol, 2007. 14(2): p. 478-83.
  19. Cummings, B.J., et al., Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C. Int J Radiat Oncol Biol Phys, 1991. 21(5): p. 1115-25.
  20. Schlienger, M., et al., Epidermoid carcinoma of the anal canal treatment results and prognostic variables in a series of 242 cases. Int J Radiat Oncol Biol Phys, 1989. 17(6): p. 1141- 51.
  21. Glynne-Jones R, Nilsson PJ, Aschele C, Goh V, Peiffert D, Cervantes A, Arnold D. Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. European Journal of Surgical Oncology. 2014 Oct 1;40(10):1165-76.
  22. Mendenhall, W.M., et al., Squamous cell carcinoma of the anal margin. Oncology (Williston Park), 1996. 10(12): p. 1843-8; discussion 1848, 1853-4.
  23. Newlin, H.E., et al., Squamous cell carcinoma of the anal margin. J Surg Oncol, 2004. 86(2): p. 55-62; discussion 63.

Для продолжения работы требуется Registration
На предыдущую страницу

Предыдущая страница

Следующая страница

На следующую страницу
Список литературы
На предыдущую главу Предыдущая глава
оглавление
Следующая глава На следующую главу